Abstract
May 3, 2022 Co-located withISCT 2022 San Francisco  After two long-awaited years, this May, ISCT held its fourth Commercialization Signature Series forum in-person co-located at ISCT 2022 San Francisco. The forum provided the opportunity for key opinion leaders in cell and gene therapy to discuss the current state of the art in manufacturing strategy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
